What is everyone's thoughts re impact on MYX? I see some positives re increased sales of antibiotics and other drugs with competitor import restrictions from Asia, but I also assume some downside from patients with non-life threatening conditions (contraceptives, some dermatology conditions) staying away from clinics to avoid exposure to COVID-19. Thoughts? I would also assume that some of MYX's manufacturing would be offshore so import restrictions may impact them as well. It's hard to get a read on it, because maybe antibiotic sales are going crazy and there's a lot of opportunity to grab share from others who can't supply...
COVID-19 impact
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.28 |
Change
0.000(0.00%) |
Mkt cap ! $362.4M | |||
| Open | High | Low | Value | Volume |
| $4.28 | $4.37 | $4.20 | $641.2K | 149.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1545 | $4.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.29 | 175 | 2 |
View Market Depth
| Last trade - 13.18pm 09/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |